Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3175 of 3546 entries
View as:

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Phase: N/A Priority: Normal
NCT ID: NCT00062894 Org: User:
Start: 04/30/03 End: 04/30/07 Due: 04/30/08

A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00431236 Org: User:
Start: 11/06/06 End: 10/09/07 Due: 10/09/08

Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque Accumulation

Phase: N/A Priority: Normal
NCT ID: NCT03703245 Org: User:
Start: 04/17/19 End: 11/11/19 Due: 11/11/20

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00985751 Org: User:
Start: 11/24/09 End: 03/02/11 Due: 03/02/12

A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT00513253 Org: User:
Start: 04/30/08 End: 05/31/08 Due: 05/31/09

Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT03614728 Org: User:
Start: 10/16/18 End: 01/11/22 Due: 01/11/23

Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03150082 Org: User:
Start: 08/01/17 End: 08/28/17 Due: 08/28/18

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00371735 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT01171157 Org: User:
Start: 05/26/09 End: 06/29/09 Due: 06/29/10

Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)

Phase: N/A Priority: Normal
NCT ID: NCT01294605 Org: User:
Start: 04/30/03 End: 09/30/04 Due: 09/30/05

A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants

Phase: N/A Priority: Normal
NCT ID: NCT06663436 Org: User:
Start: 11/13/24 End: 10/03/25 Due: 10/03/26

The Extended Salford Lung Study ("Ex-SLS") Data Access Project

Phase: N/A Priority: Normal
NCT ID: NCT03152669 Org: User:
Start: 04/15/18 End: 04/30/28 Due: 04/30/29

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Phase: N/A Priority: Normal
NCT ID: NCT06597344 Org: User:
Start: 10/02/24 End: 03/10/25 Due: 03/10/26

A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06597500 Org: User:
Start: 09/30/24 End: 12/23/24 Due: 12/23/25

Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination

Phase: N/A Priority: Normal
NCT ID: NCT01485445 Org: User:
Start: 12/21/11 End: 03/12/12 Due: 03/12/13

Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00975884 Org: User:
Start: 09/14/09 End: 04/30/10 Due: 04/30/11

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01376193 Org: User:
Start: 04/30/09 End: 10/31/11 Due: 10/31/12

Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00698893 Org: User:
Start: 05/01/92 End: 07/01/92 Due: 07/01/93

Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00069836 Org: User:
Start: 10/31/03 End: 11/30/04 Due: 11/30/05

A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients

Phase: N/A Priority: Normal
NCT ID: NCT00453778 Org: User:
Start: 11/30/02 End: 05/31/04 Due: 05/31/05

A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03201211 Org: User:
Start: 06/22/17 End: 03/19/20 Due: 03/19/21

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Phase: N/A Priority: Normal
NCT ID: NCT00871741 Org: User:
Start: 04/01/09 End: 06/25/09 Due: 06/25/10

Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT02371616 Org: User:
Start: 09/29/14 End: 12/18/14 Due: 12/18/15

Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT01248897 Org: User:
Start: 08/17/10 End: 09/05/14 Due: 09/05/15

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Phase: N/A Priority: Normal
NCT ID: NCT05590403 Org: User:
Start: 10/28/22 End: 02/12/24 Due: 02/12/25